Company Overview - First Citizens BancShares Inc. is a mid-sized U.S. bank that provides checking, savings, money market, and time deposit accounts [1] - The bank focuses on commercial construction, commercial and industrial loans, and SBA financing in its lending operations [1] Analyst Background - The analyst has over five years of experience in the Australian banking industry, enhancing their understanding of financial institutions and sharpening analytical skills in assessing bank stocks [1] - The analyst has been an active investor for more than half a decade, primarily focusing on equity markets with a target return of over 10% per annum [1] - The analyst aims to demystify the complexities of bank stocks and provide practical advice to foster a community of knowledgeable investors [1]

Company Overview - Foghorn Therapeutics Inc. is a clinical-stage biotechnology company focused on developing a new class of medicines that address serious diseases by correcting abnormal gene expression [1][3] - The company utilizes its proprietary Gene Traffic Control® platform to identify and validate drug targets within the chromatin regulatory system, with an initial emphasis on oncology [3] Upcoming Events - Management will participate in the Citizens Life Sciences Conference on May 7-8, 2025, in New York, NY, with a presentation scheduled for May 7, 2025, at 9:30 a.m. EST by CEO Adrian Gottschalk [1][2] - In addition to the conference, management will engage in one-on-one meetings on the same day [2] Product Development - Foghorn Therapeutics is developing multiple product candidates aimed at treating genetically determined dependencies within the chromatin regulatory system, particularly in the oncology sector [3] - The company's broad pipeline has the potential to significantly impact the lives of patients suffering from a variety of diseases [1]

Core Viewpoint - Ping An Insurance has established the "502 Overseas Emergency Assistance Task Force" to respond to a tragic traffic accident in the US that resulted in the deaths of five Chinese citizens and injuries to eight others [1][2]. Group 1: Emergency Response Measures - The company activated its Level 2 emergency response protocol and formed a task force led by Co-CEO Michael Guo, including various senior executives from different divisions [2]. - Specialized emergency response teams have been created across Ping An's business units, collaborating with local medical institutions and rescue organizations to provide seven key overseas emergency assistance measures [3]. Group 2: Assistance Program - Ping An is working with the Chinese Embassy and Consulate in the US to assist affected individuals and their families, launching a special assistance program available to all impacted, not just Ping An customers [4]. - An emergency hotline (95511) has been established for assistance, and as of May 3, no Ping An customers were identified as involved in the accident [4]. Group 3: Key Assistance Measures - The seven key overseas emergency assistance measures include proactive claims service, expedited claims processing, medical support, emergency assistance, simplified accidental death claims process, advance compensation for confirmed deaths, and claims processing without policy documentation [6][7]. Group 4: Company Overview - Ping An Insurance is one of the largest financial services companies globally, with over RMB 12 trillion in total assets as of December 2024, and ranked 29th in the Forbes Global 2000 list and 53rd in the Fortune Global 500 list in 2024 [8].

BETHESDA, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO of Gain, will present and participate in one-on-one meetings at The Citizens Life Sciences Conference, being held May 7th-8th in New York City, NY. Details of the presentation are as follows: Date: Thursday, ...

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens Life Sciences Conference taking place in New York on May 7, 2025. On Wednesday, May 7, 2025, at 11:00 a.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, Jane Huang, M.D., President and Chief Medical Officer, and Peggy Scherle, Ph.D., Chief Scientific Officer will participate i ...

AUSTIN, Texas, April 30, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, Ph.D., President and Chief Executive Officer, will present at The Citizens Life Sciences Conference 2025 on Thursday, May 8, 2025 at 12:00 p.m. EDT in New York, NY.A live webcast of the event can be accessed at http ...

WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at The Citizens Life Sciences Conference on Wednesday, May 7, 2025 at 12:30 p.m. ET. A live webcast of the prese ...

RALEIGH, N.C., April 24, 2025 /PRNewswire/ -- First Citizens BancShares, Inc. ("BancShares") (Nasdaq: FCNCA) reported earnings for the first quarter of 2025.Chairman and CEO Frank B. Holding, Jr. said: "Our first quarter financial results were solid, including loan growth in the Commercial Bank and SVB Commercial segments, as well as deposit growth, primarily in the Direct Bank and throughout our Branch Network. Credit remained stable with net charge-offs declining from the fourth quarter. We maintained str ...

Core Viewpoint - Citizens Financial Group (CFG) reported strong adjusted earnings per share of 77 cents for Q1 2025, exceeding estimates and reflecting an 18.4% year-over-year increase, driven by higher non-interest income and reduced expenses, despite challenges from lower net interest income and declining loan balances [1][2][10] Financial Performance - Net income on a GAAP basis was $373 million, a 12% increase from the prior year [2] - Total revenues for the quarter were $1.94 billion, slightly missing estimates by 0.3% and showing a 1.2% decline year-over-year [2] - Net interest income (NII) decreased by 4% year-over-year to $1.39 billion, attributed to a lower net interest margin and a decline in average interest-earning assets [3] - The net interest margin (NIM) shrank by 1 basis point to 2.90% [3] - Non-interest income rose by 5% year-over-year to $544 million, driven by increased service charges, wealth fees, and mortgage banking income [4] - Non-interest expenses decreased by 3% to $1.31 billion, reflecting lower costs in outside services and occupancy [5] Loan and Deposit Trends - Total loans and leases as of March 31, 2025, were $137.6 billion, down 1.1% from the prior year [6] - Total deposits increased by 1.6% to $177.6 billion [6] Credit Quality - Provision for credit losses was $153 million, down 10.5% year-over-year [7] - The allowance for credit losses decreased by 4% to $2.21 billion [7] - Net charge-offs increased by 10% to $200 million [7] - Non-accrual loans and leases rose by 8% to $1.58 billion [7] Capital Position - The tier 1 leverage ratio improved to 9.4%, up from 9.3% in the prior year [8] - The common equity tier 1 capital ratio remained stable at 10.6% [8] - The total capital ratio increased to 13.9%, compared to 13.8% in the prior year [8] Shareholder Returns - In Q1 2025, CFG repurchased $200 million of common shares and paid out $186 million in common dividends [9] Strategic Outlook - CFG's focus on strategic initiatives and efficiency improvements supports its financial performance, while a solid liquidity position allows for sustainable capital distributions [10]

Citizens Financial Group, Inc. (NYSE: CFG ) is a major regional bank we follow . As we have begun our regional bank coverage this earnings season, we have started to see some weakness in the regionals. Nothing disastrous, but someSelloff got you down? We are thriving during it at BAD BEAT InvestingWe have the right high-conviction picks and have helped our members hedge, and done well in this selloff. We also have pinpointed areas to buy during the correction. Enjoy more rapid-returns with our strategy to a ...